Rawal Pharma India Private Limited
About Rawal Pharma India Private Limited
Data last updated:
Rawal Pharma India Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 January 2017.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U93000DL2017PTC310579.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors Suman Lal Rawal and Sameer Rawal.
Its last annual general meeting (AGM) was held on 16 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Shop No 15 Cscg Dak Pitampura City, New Delhi, Delhi, India – 110034.
Company details
Contact details
Rawal Pharma India Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressShop No 15 Cscg Dak Pitampura City, New Delhi, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rawal Pharma India Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Rawal Pharma India Private Limited, buy the company report.
Board of directors of Rawal Pharma India Private Limited
Rawal Pharma India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Lal Rawal Also directs: Magnizent Pharma-Chem Private Limited | Director | 16 Jan 2017 | 9 Years 9 Months | As last reported |
| Sameer Rawal Also directs: Magnizent Pharma-Chem Private Limited | Director | 16 Jan 2017 | 9 Years 9 Months | As last reported |
Legal cases
No court or tribunal cases involving Rawal Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rawal Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rawal Pharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rawal Pharma India Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Sameer Rawal was appointed as Director on 16 Jan 2017.
Frequently asked questions
Rawal Pharma India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Rawal Pharma India was a private limited company based in New Delhi, Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 January 2017 and is registered under CIN U93000DL2017PTC310579. The company has been struck off by the Registrar of Companies and is no longer operational.
Rawal Pharma India had 2 directors:
- Suman Lal Rawal - Director
- Sameer Rawal - Director
The CIN (Corporate Identification Number) of Rawal Pharma India is U93000DL2017PTC310579. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Rawal Pharma India is at Shop No 15 Cscg Dak Pitampura City, New Delhi, Delhi, India – 110034.
Rawal Pharma India was incorporated on 16 January 2017. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Rawal Pharma India on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 16 September 2019. Year-wise statements from FY 2017 are in the company report.
Rawal Pharma India operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Sameer Rawal was appointed as Director on 16 Jan 2017. Suman Lal Rawal was appointed as Director on 16 Jan 2017.
The compliance status of Rawal Pharma India is compliant as of 05 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
